These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37863663)

  • 1. St. John's Wort Formulations Induce Rat CYP3A23-3A1 Independent of Their Hyperforin Content.
    Schäfer AM; Rysz MA; Schädeli J; Hübscher M; Khosravi H; Fehr M; Seibert I; Potterat O; Smieško M; Meyer Zu Schwabedissen HE
    Mol Pharmacol; 2023 Dec; 105(1):14-22. PubMed ID: 37863663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort.
    Gödtel-Armbrust U; Metzger A; Kroll U; Kelber O; Wojnowski L
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Aug; 375(6):377-82. PubMed ID: 17593354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John's Wort.
    Adiwidjaja J; Boddy AV; McLachlan AJ
    Clin Pharmacokinet; 2019 Jul; 58(7):911-926. PubMed ID: 30675694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
    Komoroski BJ; Parise RA; Egorin MJ; Strom SC; Venkataramanan R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6972-9. PubMed ID: 16203790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.
    Moore LB; Goodwin B; Jones SA; Wisely GB; Serabjit-Singh CJ; Willson TM; Collins JL; Kliewer SA
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7500-2. PubMed ID: 10852961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials.
    Whitten DL; Myers SP; Hawrelak JA; Wohlmuth H
    Br J Clin Pharmacol; 2006 Nov; 62(5):512-26. PubMed ID: 17010103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse.
    Cantoni L; Rozio M; Mangolini A; Hauri L; Caccia S
    Toxicol Sci; 2003 Sep; 75(1):25-30. PubMed ID: 12857935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intrauterine undernutrition on the expression of CYP3A23/3A1, PXR, CAR and HNF4alpha in neonate rats.
    Ni S; Wang X; Wang J; Lu S; Zeng S; Zhao Z; Yu L; Chen S
    Biopharm Drug Dispos; 2008 Dec; 29(9):501-10. PubMed ID: 19058292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperforin-Induced Activation of the Pregnane X Receptor Is Influenced by the Organic Anion-Transporting Polypeptide 2B1.
    Schäfer AM; Potterat O; Seibert I; Fertig O; Meyer Zu Schwabedissen HE
    Mol Pharmacol; 2019 Mar; 95(3):313-323. PubMed ID: 30573512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. St John's wort, a herbal antidepressant, activates the steroid X receptor.
    Wentworth JM; Agostini M; Love J; Schwabe JW; Chatterjee VK
    J Endocrinol; 2000 Sep; 166(3):R11-6. PubMed ID: 10974665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the haplotypes of the human pregnane X receptor gene on the basal and St John's wort-induced activity of cytochrome P450 3A4 enzyme.
    Wang XD; Li JL; Su QB; Guan S; Chen J; Du J; He YW; Zeng J; Zhang JX; Chen X; Huang M; Zhou SF
    Br J Clin Pharmacol; 2009 Feb; 67(2):255-61. PubMed ID: 19173680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose.
    Mueller SC; Majcher-Peszynska J; Uehleke B; Klammt S; Mundkowski RG; Miekisch W; Sievers H; Bauer S; Frank B; Kundt G; Drewelow B
    Eur J Clin Pharmacol; 2006 Jan; 62(1):29-36. PubMed ID: 16341856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
    J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers.
    Mueller SC; Majcher-Peszynska J; Mundkowski RG; Uehleke B; Klammt S; Sievers H; Lehnfeld R; Frank B; Thurow K; Kundt G; Drewelow B
    Eur J Clin Pharmacol; 2009 Jan; 65(1):81-7. PubMed ID: 18762932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. St. John's Wort alleviates dextran sodium sulfate-induced colitis through pregnane X receptor-dependent NFκB antagonism.
    Yan T; Luo Y; Xia Y; Hamada K; Wang Q; Yan N; Krausz KW; Ward JM; Hao H; Wang P; Gonzalez FJ
    FASEB J; 2021 Nov; 35(11):e21968. PubMed ID: 34644426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures.
    Komoroski BJ; Zhang S; Cai H; Hutzler JM; Frye R; Tracy TS; Strom SC; Lehmann T; Ang CY; Cui YY; Venkataramanan R
    Drug Metab Dispos; 2004 May; 32(5):512-8. PubMed ID: 15100173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin.
    Hohmann N; Friedrichs AS; Burhenne J; Blank A; Mikus G; Haefeli WE
    Clin Transl Sci; 2024 Aug; 17(8):e70007. PubMed ID: 39152679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of St John's wort on the pharmacokinetics of docetaxel.
    Goey AK; Meijerman I; Rosing H; Marchetti S; Mergui-Roelvink M; Keessen M; Burgers JA; Beijnen JH; Schellens JH
    Clin Pharmacokinet; 2014 Jan; 53(1):103-10. PubMed ID: 24068654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression?
    Gutmann H; Poller B; Büter KB; Pfrunder A; Schaffner W; Drewe J
    Planta Med; 2006 Jun; 72(8):685-90. PubMed ID: 16755466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.